Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03592290 · ClinicalTrials.gov registry record
Hemodynamics Monitoring During Lower Body Negative Pressure (LBNP) Induced Controlled Hypovolemia
A clinical trial of Hemodynamic Instability and Hypovolemia, sponsored by Yale University.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT03592290: Recruiting study of Hemodynamic Instability and Hypovolemia, sponsored by Yale University.
NCT03592290 is a study of Hemodynamic Instability and Hypovolemia that is actively recruiting participants, run by Yale University. The registered enrollment target is 120 participants, below the 6,281-participant average among 5 other Hemodynamic Instability trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03592290, a study of Hemodynamic Instability and Hypovolemia, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
To monitor the changes in central and peripheral monitors/waveforms during gradual hypovolemia induced by lower body negative pressure in healthy volunteers.
Primary Outcome
Data will be summarized using mean (SD) for normally distributed data, median (interquartile range) for non-normal data. linear regression method will be used to model the changes of our dependent variable from baseline during blood loss.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Lower body negative pressure
Study Locations (1)
Connecticut
- John B. Pierce Laboratory - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2027-01 |
What NCT03592290 shows while recruiting
NCT03592290 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 6,281-participant average among 5 other Hemodynamic Instability trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Hemodynamic Instability appearing as the primary indexed condition, and to 1 intervention - of which Lower body negative pressure is the first listed.
NCT03592290 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT03592290 about?
NCT03592290 is a clinical study titled "Hemodynamics Monitoring During Lower Body Negative Pressure (LBNP) Induced Controlled Hypovolemia". To monitor the changes in central and peripheral monitors/waveforms during gradual hypovolemia induced by lower body negative pressure in healthy volunteers.
What is the current status of trial NCT03592290?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2017-11-15. Estimated completion is 2027-01.
What conditions does trial NCT03592290 study?
This clinical trial studies the following conditions: Hemodynamic Instability, Hypovolemia.
What interventions are being tested in trial NCT03592290?
The interventions under investigation include: Lower body negative pressure (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03592290?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03592290 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemodynamic Instability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
HemoSphere Alta Study
RECRUITING
-
Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy
RECRUITING
-
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
ACTIVE NOT RECRUITING · NA
-
Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI